Molecular Approaches Fighting Nonsense II
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 1967
Special Issue Editors
Interests: synthesis of heterocyclic compounds; heterocyclic chemistry; medicinal and pharmaceutical chemistry; synthetic medicinal chemistry; natural product chemistry; materials chemistry; applied organic chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nonsense mutations are a genetic change involved in about 10% of genetic diseases (cystic fibrosis, Duchenne muscular dystrophy, b-thalassemia, retinitis pigmentosa, congenital blindness, dystonia, spinal muscular atrophy, neurofibromatosis, lysosomal storage disease, Usher’s syndrome, hemophilia, Tay–Sachs disease, Schwackman Diamond syndrome, etc.).
This change causes the formation of a premature termination codon (PTC) in the mRNA encoded by a specific gene. This particular class of mutations is usually associated with a reduction in the level of cytoplasmic mRNA by the nonsense-mediated decay pathway (NMD).Therefore, the main problem caused by this genetic alteration is twofold: on the one hand, the reduced concentration of transcript, and on the other hand, the production of an unfunctional truncated polypeptide. To overcome these problems, different approaches have been proposed. One of the first strategies proposed is the readthrough approach, with the identification and use of small molecules, named translational readthrough-inducing drugs (TRIDs), allowing the overcoming of the premature stop codon. Another way is genetic editing by CRISPR technology, working on the genetic defect. Finally, a very recent emergent approach is the use of synthetic tRNA, able to recognize the premature stop codon during the translation process.
Pharmacological approaches to nonsense suppression are a fascinating field in view of a wider application to different genetic diseases whose common denominator is the presence of a premature stop codon in the mRNA.
In this Special Issue, we aim to collect different contributions in the form of recent and innovative research in the field of nonsense mutations.
Dr. Ivana Pibiri
Dr. Laura Lentini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
